Vimarsana
Biggest News Aggregation in the World

Page 11 - Azenta News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Azenta. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Azenta Today - Breaking & Trending Today

Azenta to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference - Vimarsana News

Azenta to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference

/PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that Company management will participate in the Morgan Stanley 21st Annual Global Healthcare...

Azenta to Participate in the Baird 2023 Global Healthcare Conference - Vimarsana News

Azenta to Participate in the Baird 2023 Global Healthcare Conference

/PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that Company management will participate in the Baird 2023 Global Healthcare Conference in New...

Estimating The Fair Value Of Azenta, Inc. (NASDAQ:AZTA) - Vimarsana News

Estimating The Fair Value Of Azenta, Inc. (NASDAQ:AZTA)

Key Insights Using the 2 Stage Free Cash Flow to Equity, Azenta fair value estimate is US$70.19 Current share price of...

Source: yahoo.com
119,513 Shares in Azenta, Inc. (NASDAQ:AZTA) Acquired by HRT Financial LP - Vimarsana News

119,513 Shares in Azenta, Inc. (NASDAQ:AZTA) Acquired by HRT Financial LP

HRT Financial LP bought a new position in Azenta, Inc. (NASDAQ:AZTA – Free Report) during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 119,513 shares of the company’s stock, valued at approximately $5,332,000. HRT Financial LP owned about 0.17% of Azenta as […]

Analysts Set Azenta, Inc. (NASDAQ:AZTA) Target Price at $64.50 - Vimarsana News

Analysts Set Azenta, Inc. (NASDAQ:AZTA) Target Price at $64.50

Shares of Azenta, Inc. (NASDAQ:AZTA – Get Free Report) have been given an average rating of “Moderate Buy” by the five brokerages that are currently covering the company, MarketBeat.com reports. Two equities research analysts have rated the stock with a hold recommendation and three have assigned a buy recommendation to the company. The average twelve-month […]

Source: wkrb13.com